Introduction
growth factor (PDGF), 6,7 basic fibroblast growth factor (bFGF) 8, 9 and transforming growth factor beta (TGF-). 10 These act as potent mitogens for medial VSMCs, Vascular smooth muscle cell (VSMCs) proliferation and inducing a phenotypic ''switch'' from a quiescent conmigration along with the remodelling of extracellular tractile state to a secretory proliferative form. This matrix proteins (ECM) result in a hyperplastic intimal pivotal change is known as modulation. 11,12 Medial lesion. These are pathophysiological responses to a VSMC proliferation and migration through the internal variety of stimuli including growth, hypertension and elastic lamina requires the degradation of ECM and arterial injury. The formation of this ''neointima'' and subsequently synthesis and deposition of new extrasubsequent lumenal narrowing are responsible for the cellular proteins. Vascular smooth muscle cells are failure of arterial reconstructive procedures in bypass capable of producing metalloproteinases (MMPs) and surgery, 1 restenosis following transluminal anserine proteases as well as ECM. MMPs are a family gioplasty 2 and arterial vasculopathy in transplanted of Zn
2+
-dependent proteases that differ widely in subgrafts. 3 Importantly, intimal hyperplasia predisposes to strate specificity and are not only capable of degrading superimposed atherosclerotic changes, plaque rupture matrix, but can also activate other metalloproteinases. 13 and vessel occlusion.
4,5
Secretion of metalloproteinases, principally MMP-2 Following mechanical or immune-mediated arterial and 9 facilitate the migration of VSMCs across the injury macrophages, platelets and VSMCs release a internal elastic laminae, whilst TIMPs inhibit this promyriad growth factors including platelet-derived cess. 14 Conversely, extracellular matrix deposition is characterised by a relative increase in protease in- * Please address all correspondence to: J. R. Waller, Royal College hibition. 15 Inhibition of metalloproteinases therefore of Surgeons of England Surgical Research Fellow, University De-may offer a therapeutic strategy for the prevention of bypass graft survival or prevent restenosis following Sirius red staining balloon angioplasty.
To date, no pharmacological agents have proved Carotid arteries were formalin fixed, embedded in epoxy resin and cut into 4 m sections. The resin was effective in the clinical setting. Pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) is a novel anti-fibrotic and removed in xylene for 10 min and dehydrated in serial washes of 100% alcohol for 2 min performed twice, anti-proliferative agent which has been shown to inhibit smooth muscle cell proliferation and deposition 95%, 80% and 60% alcohol for 2 min. Sections were run under cold running water for 10 min and finally of ECM proteins in animal models of fibrosis. [16] [17] [18] In the present study, we administered pirfenidone to rinsed briefly with distilled water. Staining was performed overnight for 12 h in picro-sirius red F3BA assess its effect on the development of the neointima.
(0.1% Sirius red F3BA in saturated aqueous picric acid). Rapid dehydration was repeated with an initial wash of 0.01 M HCl for 2 min, and serial washes of 70% alcohol for 45 s followed by 80%, 95% and 100% Material and Methods for 2 min. Slides were cleared with 2 washes of xylene for 2 min, excess xylene removed and slides mounted Arterial injury model with Xam organic mountant. Ten random windows of intima were analysed and the value of extracellular Four-month-old male Sprague-Dawley rats (weighing matrix was determined from the mean of these 350-400 g) were obtained from Harland (Cambridge, windows. U.K.). Rats were anaesthetised with halothane and were cared for in accordance with Animals (Scientific Procedures) Act 1986. The left common carotid artery Molecular analysis was denuded of endothelium with a saline-filled 2F balloon embolectomy catheter (Baxter Healthcare The methods used to quantify levels of mRNA expression using reverse transcriptase-polymerase chain Corp) as described previously. 19 In brief, the catheter was introduced through the left external carotid artery reaction (RT-PCR) have been described previously. 20 In brief, vessels were cut into 10 m sections and into the common carotid. Denudation was performed by inflating the catheter to a pressure of 2 atmospheres ground under liquid nitrogen in a mortar and pestle.
Messenger RNA was extracted using oligo-dT-linked and passing it in a twisting manner from the arch of the aorta to the carotid bifurcation. This procedure Dynabeads (Dynal, Bromborough, U.K.). Competitive reverse transcriptase-polymerase chain reaction (RTwas repeated twice more before the catheter was removed and the external carotid ligated.
PCR) was performed as described previously. Genes chosen for quantification in this study included matrix The rats were anaesthetised at 4, 8, 14 and 28 days post balloon injury and the left common carotid artery metralloproteinases (MMPs)-2 and 9, tissue inhibitor of metalloproteinases (TIMP-1), matrix protein colflushed with phosphate-buffered saline. The middle third of each vessel was used for histomorphometry lagen III and transforming growth factor-(TGF-).
All probes and primers were designed from sequences and the outer thirds snap frozen in liquid nitrogen and stored at −70°C for molecular studies.
available on the EMBL database using the program GCG prime (Genetics Computer Group, Madison, Wisconsin, U.S.A.) and synthesised by Life Technologies (Paisley, U.K.) or Genosys Biotechnologies Europe (Pampisford, U.K.). Quantification of RT-PCR prodMorphology ucts was performed using an enzyme-linked immunosorbent assay. Differences in tissue cellularity Vessels for histological study were not pressure per-were corrected for by expressing values of comfused but fixed with 2.5% gluteraldehyde in 0.1 M plementary DNA product as a ratio to that of conphosphate buffer (pH 7.4). After 16 h further fixation, stitutively expressed housekeeping gene, -actin. the vessels were embedded in epoxy resin and cut into 2 m transverse sections. Intimal and medial areas were assessed using light microscope assisted comGelatin zymography puter planimetry. Intimal and medial areas were defined by internal and external elastic laminae Metalloproteinases were extracted from frozen tissue as described previously. 21 Briefly, frozen tissue was respectively. thawed over ice, weighed, chopped into 1 mm 2 pieces and homogenised in buffer (urea 2 mM, Tris-HCl 50 mM pH 7.6, NaCl 137 mM, EDTA 1 g/l, Brij-35 1/ ml/l and PMSF 0.1 mM -all Sigma, Poole, (U.K.). The homegenate was then centrifuged at 12 000 g for 1 h at 4°C and the resulting supernatants dialysed (12-14 000 kDa) against a dialysing buffer (Tris 25 mM pH 8.5, CaCl 2 10 mM, 0.1% Brij-35, 0.1 mM PMSF) for 18 h att 4°C. The protein concentration of each sample was standardised as described previously. 22 Equivalent protein loads (15 g ) were resolved by a non-reducing electrophoresis through a 10% SDS-polyacrylamide gel impregnated with 1 mg/ml gelatin. The human fibrosarcoma cell line, HT-1080, was loaded onto each gel as a positive control. SDS was removed from the gels by incubation in 2.5% Triton X-100 (3×15 min) and the gels immersed for 16 h in incubation buffer (50 mM Tris-HCl, 10 mM CaCl and 0.05% Brij-35, pH 7.4) at 37°C. Gels were fixed and stained in 0.1% Coumassie brilliant blue in 50% methanol/20% acetic were visualised as clear bands of lysis against a dark 6 rats at 14 days. Chi square=17.3; df=3; p<0.001. background of intact substrate. The relative density of each lytic band was determined from negative showed 10% weight loss over this period compared photographic images of gels with a Pharmacia LKB to controls and thus pirfenidone was administered at Imagemaster scanning densitometer (Pharmacia LKB, a dose of 500 mg/kg/day throughout the remainder St. Albans, Herts, U.K.) and expressed as a product of of the study. the optical density and area of the band. This method ''Uninjured'' rat arteries do not contain smooth provides a semi-quantitative analysis of metallo-muscle cells in the intima. 23 However, smooth muscle proteinase activity.
cells appeared in the intima of untreated rats 4 days post arterial injury, median intima medial ratio 0.08 (range 0.04-0.14) (Fig. 2A) . Smooth muscle migration was completely inhibited by continuous daily oral Statistical analysis administration of pirfenidone at 500 mg/kg/day (p<0.002) (Fig. 2) . Intimal thickening was reduced in Intima medial ratios, collagen staining and RT-PCR pirfenidone treated rats at day 8, intima medial ratio data are presented as median±range from 6 animals 0.38 (range 0.11-0.61) compared with controls, intima per group. Differences between control and treatment medial ratio 0.54 (range 0.26-0.93), p<0.01 (Figures 2C groups were calculated using non-parametric analysis and D respectively). A significant reduction in intimal (Mann-Whitney U-test). The relative density of sub-thickening was also observed at 14 days, intima medial strate gel lysis was quantified from 3 carotids in each ratio 0.49 (range 0.12-0.85) versus untreated rats, intreatment group and run on the same gel. Differences tima medial ratio 1.54 (range 1.02-2.04) p<0.001 (Figwere again expressed using non-parametric analysis. ures 2E and F respectively). However, no significant Differences were considered significant at Ζ0.05. differences in intimal thickening were observed at 28 days ( Figures 2G, H and Figure 3 ). Pirfenidone had no significant effect on medial area compared with controls at any time point (data not shown).
Results

Stereological analysis
Effect of pirfenidone on -actin mRNA expression Pirfenidone inhibited intimal thickening at 14 days in a dose-dependent manner (p<0.001) (Fig. 1) . Animals RT-PCR was performed on carotid arteries from both control and treated animals to assess whether -actin treated with pirfenidone at a dose of 1 g/kg/day (mRNA) expression is stated in arbitary units and expressed as a ratio to that of housekeeping gene -actin.
mRNA expression was affected by the administration of pirfenidone. No differences were found between control and treated animals at any time point assessed, confirming that expression of the house-keeping gene -actin was not affected by either balloon injury or treatment with pirfenidone (data not shown).
Effect of pirfenidone on pro-fibrotic gene expression
The results at 14 days are shown in Figure 4 and expressed as mean values (±SEM). Gene data presented is standardised relative to the house-keeping 
Metalloproteinase activity
A representative gelatin zymogram is shown in Figure  6 . Control samples demonstrated lytic bands at 92 kDa, 82 kDa and 72 kDa consistent with MMP-9, pro and active forms of MMP-2 respectively. Pirfenidonetreated samples also demonstrated clear lytic bands corresponding to pro and active MMP-2. However, densitometric analysis showed a significant reduction in MMP-9 activity in pirfenidone-treated carotids at day 4, median value 0.1 (range 0.02-0.2) compared with controls, 0.39 (0.27-0.63) p<0.002. Pro and active MMP-2 were reduced in pirfenidone-treated carotids at day 4 although this failed to reach statistical significance (p<0.1). MMP-9 activity was not detected at any other time point, consistent with previous findings. 24 There were no significant differences in pro and active MMP-2 activity at any other time point.
Extracellular matrix deposition
Pirfenidone attenuated neointimal extracellular matrix deposition at 28 days; median value 15 (range 12-19) compared with controls, 9 (range 7-12) (p<0.002). 
Discussion
This study shows pirfenidone to inhibit early vascular smooth muscle proliferation and migration following no effect on metalloproteinase expression at this later time point (Fig. 5) . arterial injury but fails to inhibit late intimal proliferation at 28 days. Furthermore, the gene data preVascular smooth muscle cells constitutively express MMP-2 under basal conditions whilst MMP-9 exsented suggests that its mechanism of action is due to inhibition of MMP 2 and 9 transcription. Gelatin pression is induced by arterial injury. 25 It is therefore likely that the observed reduction in early intimal zymography showed pirfenidone to significantly inhibit MMP-9 activity. Whilst the reduction in pro thickening is attributable to inhibition of MMP-2 and 9 in rats treated with pirfenidone. Previous studies and active MMP-2 activity failed to reach statistical significance (p<0.065 and p<0.093 respectively), it is using metalloproteinase inhibitors support this hypothesis: Southgate et al. showed synthetic MMP inlikely that pirfenidone also has an inhibitory effect on MMP-2 activation. Despite significant differences in hibitors significantly inhibited smooth muscle cell proliferation and migration from rabbit aortic explants intimal lesion size at day 14, continued administration of pirfenidone failed to confer this reduction in intimal in vivo 26 and Bendeck et al. showed a significant reduction in intimal hyperplasia up to 10 days post rat thickening to 28 days. Additionally, pirfenidone had deposition has been previously observed in a bleomycin hamster model of fibrosis and this also occurred at a transcriptional level.
38
In conclusion, we have shown pirfenidone to attenuate early intimal thickening and significantly inhibit metalloproteinase gene expression governing medial smooth muscle cell proliferation and migration, and collagen deposition. The findings of this study support the hypothesis that metalloproteinases are pivotal mediators in vascular smooth muscle cell proliferation and migration. However we have shown that inhibition of carotid ballon injury using the non-selective MMPAcknowledgements inhibitor GM-6001. but returns to baseline levels by day 7. 31 We have idiopathic pulmonary fibrosis. 36 Its effect in models of 
